Editorial: Optimizing current blood utilization practices in perioperative patients using the lean team approach.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26440229)

Published in Ann Card Anaesth on October 07, 2015

Authors

Eduardo S Rodrigues1, Harish Ramakrishna

Author Affiliations

1: Department of Anesthesiology, Mayo Clinic, Jacksonville, Florida 32224, USA.

Articles cited by this

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med (1999) 20.31

Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med (2013) 10.19

Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med (2011) 7.52

Liberal or restrictive transfusion after cardiac surgery. N Engl J Med (2015) 6.69

Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med (2012) 5.77

Transfusion requirements in surgical oncology patients: a prospective, randomized controlled trial. Anesthesiology (2015) 5.52

Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA (2014) 5.33

Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg (2007) 5.32

Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev (2012) 4.14

Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA (2010) 4.13

Variation in transfusion rates within a single institution: exploring the effect of differing practice patterns on the likelihood of blood product transfusion in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg (2014) 1.52

Variation of blood transfusion in patients undergoing major noncardiac surgery. Ann Surg (2013) 1.00

A systematic review to identify the factors that affect failure to rescue and escalation of care in surgery. Surgery (2015) 1.00

Articles by these authors

A core review of temperature regimens and neuroprotection during cardiopulmonary bypass: does rewarming rate matter? Anesth Analg (2009) 2.27

Survey of the National Drug Shortage Effect on Anesthesia and Patient Safety: A Patient Perspective. Anesth Analg (2015) 2.02

Brugada syndrome and its relevance in the perioperative period. Ann Card Anaesth (2015) 1.43

Emergent cardiopulmonary bypass during pectus excavatum repair. Ann Card Anaesth (2013) 0.90

Recent advances in chronic thromboembolic pulmonary hypertension. J Cardiothorac Vasc Anesth (2011) 0.84

Cerebral Venous Thrombosis: Current and Newer Anticoagulant Treatment Options. Neurologist (2015) 0.82

Endovascular repair of expanding thoracic aortic aneurysms in high surgical risk patients. Ann Card Anaesth (2016) 0.81

N-terminal pro B type natriuretic peptide in high cardiovascular-risk patients for noncardiac surgery: What is the current prognostic evidence? Ann Card Anaesth (2016) 0.80

Challenges after the first decade of transcatheter aortic valve replacement: focus on vascular complications, stroke, and paravalvular leak. J Cardiothorac Vasc Anesth (2012) 0.77

Recent advances in the management of coronary artery disease: highlights from the literature. J Cardiothorac Vasc Anesth (2009) 0.77

Current approach to diagnosis and treatment of delirium after cardiac surgery. Ann Card Anaesth (2016) 0.75

Converting data into information and knowledge: The promise and the reality of electronic medical records. Ann Card Anaesth (2015) 0.75

Outcomes of ≤6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation: A meta-analysis and meta-regression. Medicine (Baltimore) (2016) 0.75

Laparoscopic colectomy in an adult with single ventricle physiology: anesthetic implications and management. Ann Card Anaesth (2015) 0.75

Anesthetic pharmacology and perioperative considerations for the end stage liver disease patient. Curr Clin Pharmacol (2015) 0.75

Veno-Venous Extracorporeal Life Support in Hemodynamically Unstable Patients With ARDS. Anesth Analg (2016) 0.75

Perioperative venous thromboembolic disease and the emerging role of the novel oral anticoagulants: An analysis of the implications for perioperative management. Ann Card Anaesth (2015) 0.75

Emergent echocardiography in noncardiac surgical patients. J Cardiothorac Vasc Anesth (2012) 0.75

The year in cardiothoracic and vascular anesthesia: selected highlights from 2010. J Cardiothorac Vasc Anesth (2011) 0.75

Lung transplantation: perioperative pharmacology and anesthetic considerations. Curr Clin Pharmacol (2015) 0.75

Advances in drug safety. Curr Pharm Des (2012) 0.75

Case 1--2010 Pulmonary thrombectomy in an adult with fontan circulation. J Cardiothorac Vasc Anesth (2010) 0.75

Heart transplantation in the era of continuous flow ventricular assist devices and the total artificial heart: will new technologies surpass the gold standard? Ann Card Anaesth (2011) 0.75

Direct Xa inhibitors in addition to antiplatelet therapy in acute coronary syndrome: meta-analysis of randomized trials. Coron Artery Dis (2017) 0.75

Intermittent obstruction of left ventricular assist device due to prolapsing papillary muscle. Ann Card Anaesth (2012) 0.75

Pulmonary hypertension in patients undergoing cardiac surgery: pathophysiology, perioperative management, and outcomes. J Cardiothorac Vasc Anesth (2012) 0.75

In Response. Anesth Analg (2017) 0.75

Ondansetron and carpopedal spasm. Can J Anaesth (2008) 0.75

The year in Cardiothoracic and Vascular Anesthesia: selected highlights from 2011. J Cardiothorac Vasc Anesth (2012) 0.75